RLMD reports a GAAP loss per share of $0.22, falling short of expectations as R&D expenses decline year-over-year. Relmada Therapeutics posted a first-quarter GAAP earnings per share loss of $0.22, missing estimates by $0.02. The result reflects ongoing investment in clini
Major US indices closed mixed as tech shares retreated sharply while the Dow industrials edged higher in sector rotation. US equities ended the session mixed as a rotation out of technology stocks weighed on the Nasdaq and S&P 500, while the Dow industrials posted modest g
Evolv's Q1 2026 revenue rose 44.7% year-over-year to $46.3M, exceeding expectations by $2.6M. Evolv Technologies reported Q1 2026 revenue of $46.3M, a 44.7% increase year-over-year and $2.6M above estimates. Non-GAAP EPS matched expectations at -$0.02. The company's
GrowGeneration reports $38.39M in Q1 revenue, exceeding expectations by $1.94M while GAAP EPS aligns at -$0.08. GrowGeneration posted Q1 revenue of $38.39 million, up 7.5% year-over-year and $1.94 million above estimates. GAAP earnings per share matched expectations at -$0
WNRS shares will consolidate at a 300-to-1 ratio on May 13, cutting outstanding shares to approximately 53.1 million. Winners announced its board approved a 1-for-300 reverse stock split, set to take effect May 13. The move will combine every 300 outstanding shares into on
Investors react to stalled updates on a potential $32 per share bid for the casino operator by Fertitta Entertainment. Caesars Entertainment (CZR) shares dropped 9% in trading as investors await clarity on a potential sale of the company. Reports in recent months indicated
Tel-Aviv Stock Exchange reports record adjusted EBITDA of NIS 115.6 million, up 87% year-over-year. The Tel-Aviv Stock Exchange posted Q1 2026 revenue of NIS 183.3 million, a 40% increase from the same period last year. The jump reflects stronger trading volumes and higher
IMNN confirms Phase III trial progress, targeting final enrollment milestone for its OVATION 3 study next year. Imunon announced plans to complete last patient enrollment for its pivotal Phase III OVATION 3 study in Q1 2029. The company cited strong momentum following the
Tencent Music Entertainment highlights copyright enforcement and WeChat Channels integration to counter competitive pressures in music streaming. Tencent Music Entertainment Group (TME) delivered a steady performance in Q1 2026 despite intensifying competition in the music
Janus International reaffirms its 2026 revenue guidance despite subdued demand and macroeconomic challenges in Q1. Janus International Group maintained its 2026 revenue forecast of $940M-$980M, citing resilience in a challenging macroeconomic environment. The company noted
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.